Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer

Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer

(2011) Jayme B. Stokes et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response

(2010) O. Turrini et al.   EJSO

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review

(2009) R. Le Scodan et al.   ANNALS OF ONCOLOGY

Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma

(2009) Thomas Schnelldorfer et al.   ANNALS OF SURGERY

Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer

(2009) Hiroaki Ohigashi et al.   ANNALS OF SURGERY

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

(2009) Matthew H. G. Katz et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant Chemoradiation in Patients With Potentially Resectable Pancreatic Cancer

(2009) Soichiro Takai et al.   PANCREAS

Surgical Results After Preoperative Chemoradiation Therapy for Patients With Pancreatic Cancer

(2009) Sohei Satoi et al.   PANCREAS

Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer

(2008) Hee Man Kim et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Survival After Pancreatoduodenectomy for Ductal Adenocarcinoma

(2008) Edward L. Bradley   PANCREAS

Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma

(2008) Mustapha Adham et al.   PANCREAS